<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The outcome of primary sclerosing <z:mp ids='MP_0003254'>cholangitis</z:mp> (PSC) has improved by liver transplantation (LT), but patients often develop <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We analysed morbidity and mortality patterns to define strategies to prevent complications </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Two hundred consecutive patients diagnosed before October 2005 were studied </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">Malignancies</z:e> developed in 40 (20%) and led to <z:hpo ids='HP_0011420'>death</z:hpo> in 28 patients (45.9% of the 61 mortalities) </plain></SENT>
<SENT sid="4" pm="."><plain><z:mpath ids='MPATH_354'>Cholangiocarcinoma</z:mpath> (CCa) developed in 13 patients, and was detected shortly after the diagnosis of PSC in 31% </plain></SENT>
<SENT sid="5" pm="."><plain>Colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> were documented in 10 and dysplastic <z:mpath ids='MPATH_270'>adenomas</z:mpath> in four patients; eight had <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>, two Crohn's <z:hpo ids='HP_0002583'>colitis</z:hpo>, one unclassified <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBDu), three had no IBD </plain></SENT>
<SENT sid="6" pm="."><plain>Five died of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Three <z:mp ids='MP_0002038'>carcinomas</z:mp> and two <z:mpath ids='MPATH_270'>adenomas</z:mpath> were localized in the caecum or ascending colon, but most (n=10) in the recto-sigmoidal region </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0001402'>Hepatocellular carcinoma</z:hpo> developed in three patients with advanced <z:mp ids='MP_0003045'>fibrosis</z:mp>/<z:hpo ids='HP_0001394'>cirrhosis</z:hpo>, and <z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo> in five </plain></SENT>
<SENT sid="9" pm="."><plain>LT has been carried out in 42 patients, 6.1 years (median, 0.5-25) after the diagnosis of PSC </plain></SENT>
<SENT sid="10" pm="."><plain>Mortality was due to hepatic complications in 13 patients </plain></SENT>
<SENT sid="11" pm="."><plain>Within 5 years of the diagnosis, <z:hpo ids='HP_0011420'>deaths</z:hpo> were because of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in 12 patients and to hepatobiliary decompensation in only three, whereas 18 had been transplanted </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: Since the use of transplantation, <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> are the major cause of <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>CCa has to be searched for in any new symptomatic patient </plain></SENT>
<SENT sid="14" pm="."><plain>Colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> occurs frequently </plain></SENT>
<SENT sid="15" pm="."><plain>Colonoscopy at the diagnosis of PSC is obligatory and should be repeated at 1-2 years interval in the patients with IBD and every 5 years in those without IBD </plain></SENT>
</text></document>